Verve Therapeutics Inc (VERV)

Verve Therapeutics Inc Azioni (VERV) Dati Finanziari

Conto economico

Trimestrale

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	10.71% 5.695	5.144	3.117	2.093	1.404
Operating Expenses	5.83% 62.54	59.09	55.45	60.68	59.66
Benefits Costs and Expenses	1.61% 54.33	53.46	48.81	55.90	53.38
Costs And Expenses	5.83% 62.54	59.09	55.45	60.68	59.66
Depreciation and Amortization	7.58% 1.632	1.517	1.474	1.337	1.127
Operating Income/Loss	5.37% -56.84	-53.95	-52.33	-58.58	-58.26
Nonoperating Income/Loss	45.95% 8.214	5.628	6.643	4.776	6.284
Income/Loss From Continuing Operations Before Tax	0.64% -48.63	-48.32	-45.69	-53.81	-51.98
Income Tax Expense/Benefit	231.25% 0.106	0.032	0.067	0.176	-
Income/Loss From Continuing Operations After Tax	0.79% -48.74	-48.35	-45.76	-53.98	-51.98
Net Income/Loss	0.79% -48.74	-48.35	-45.76	-53.98	-51.98
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	4,388% 83.13	1.8522	63.21	61.95	61.79
Diluted Average Shares	4,388% 83.13	1.8522	63.21	61.95	61.79
Basic Earnings Per Share	14.49% -0.59	-0.69	-0.72	-0.87	-0.84
Diluted Earnings Per Share	14.49% -0.59	-0.69	-0.72	-0.87	-0.84
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-